DrugsControl Media Services

News Detail

Serum Institute gets nod to resume Oxford Covid-19 vaccine trial (16-09-2020)

New Delhi, 16 Sept 2020: The Drugs Controller General of India (DCGI) gave permission to Pune Serum Institute of India (SII) to resume its phase two and three clinical trials of the Oxford Covid-19 vaccine candidate in the country.

DCGI VG Somani, in a letter to SII......
View Details

Source : Livemint

Related News